Упрощенная HTML-версия
188
84.
Kumar S. Evidences showing association of interleukin-1B
polymorphisms with increased risk of gastric cancer in an Indian population /
S. Kumar, A. Kumar, V.K. Dixit // Biochemical and biophysical research
communications. – 2009. – Vol. 387, №3. – P.456-460.
85.
Kundu J.K. Inflammation: gearing the journey to cancer / J.K.
Kundu, Y.J. Surh // Mutation research. – 2008. – Vol.659, № 1-2. – P.15-30.
86.
Lahner E. Is interleukin-1 genotyping useful for the clinical
management of patients with atrophic body gastritis? / E. Lahner [et al.] //
Alimentary pharmacology & therapeutics. – 2008. – Vol.27, №4. – P.355-
365.
87.
Laurén P. The two histological main types of gastric carcinoma:
diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical
classification / P. Laurén // Acta pathologica et microbiologica Scandinavica.
– 1965. – Vol. 64. – P. 31-49.
88.
Lee S.G. Lack of association between pro-inflammatory genotypes of
the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric
cancer/duodenal ulcer in Korean population / S.G. Lee [et al.] //Cytokine. –
2003. – Vol.21, №4. – P.167-171.
89.
Leung W.K. Microsatellite instability in gastric intestinal metaplasia
in patients with and without gastric cancer / W.K. Leung [et al.] // The
American journal of pathology. – 2000. – Vol. 156, № 2. – P. 537-543.
90.
Li C. Association between interleukin-1 gene polymorphisms and
Helicobacter pylori infection in gastric carcinogenesis in a Chinese population
/ C. Li [et al.] // Journal of gastroenterology and hepatology. – 2007. – Vol.22,
№2. – P.234-239.
91.
Lochhead P. Helicobacter pylori infection and gastric cancer / P.
Lochhead, E.M. El-Omar // Best practice & research. Clinical
gastroenterology. – 2007. – Vol. 21, № 2. – P. 281-297.